BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9371549)

  • 1. Influence of extracellular K+ concentration on the time-course of Na+/K+-ATPase inhibition by cardiac glycosides with fast and low binding kinetics.
    Gleitz J; Peters M
    Eur J Pharmacol; 1997 Sep; 335(1):89-97. PubMed ID: 9371549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
    Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
    Venter PA; Naudé RJ; Oelofsen W; Swan GE
    Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
    Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
    Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
    Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
    Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium changes the relationship between receptor occupancy and the inotropic effect of cardiac glycosides in guinea-pig myocardium.
    Bachmaier A; Ebner F; Reiter M
    Br J Pharmacol; 1985 Aug; 85(4):755-65. PubMed ID: 4041678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
    Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
    J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cardiac glycosides on the Na+ pump current-voltage relationship of isolated rat and guinea-pig heart cells.
    Hermans AN; Glitsch HG; Verdonck F
    J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):279-91. PubMed ID: 7738826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
    Pôças ES; Costa PR; da Silva AJ; Noël F
    Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of palytoxin and cardiac glycosides on erythrocyte membrane and (Na+ + K+) ATPase.
    Ozaki H; Nagase H; Urakawa N
    Eur J Biochem; 1985 Oct; 152(2):475-80. PubMed ID: 2865137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization, quantitation, similarity evaluation and combination with Na
    Bai Y; Zhu W; Xu Y; Xie Z; Akihisa T; Manosroi J; Sun H; Feng F; Liu W; Zhang J
    Bioorg Chem; 2019 Jun; 87():265-275. PubMed ID: 30908969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The heterogeneity of the Na+, K(+)-ATPase ouabain sensitivity in microsomal membranes of rat colon smooth muscles].
    Kaplia AA
    Ukr Biokhim Zh (1999); 2011; 83(5):89-93. PubMed ID: 22276432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
    Gupta RS; Chopra A
    J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding properties and biological effects of oxidized-ouabain on cultured neonatal-rat cardiac myocytes. Implications on the mechanism of action of the digitalis-glycosides.
    Hallaq H; Heller M; Panet R; Eilam Y
    Biochem Pharmacol; 1991 Feb; 41(4):509-19. PubMed ID: 1847634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoresceinyl-ethylenediamine-ouabain detects an acidic environment in the cardiac glycoside binding site of Na+/K+-ATPase.
    Brinkmann K; Linnertz H; Amler E; Lanz E; Herman P; Schoner W
    Eur J Biochem; 1997 Oct; 249(1):301-8. PubMed ID: 9363783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of Na/K-ATPase alpha-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli.
    Huang L; Kometiani P; Xie Z
    J Mol Cell Cardiol; 1997 Nov; 29(11):3157-67. PubMed ID: 9405189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative ability of digoxin and an aminosugar cardiac glycoside to bind to and inhibit Na+,K+-adenosine triphosphatase. Effect of potassium.
    Songu-Mize E; Gunter JL; Caldwell RW
    Biochem Pharmacol; 1989 Nov; 38(21):3689-95. PubMed ID: 2557026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
    Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
    Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.